Urocortin 2: will a drug targeting both the vasculature and the right ventricle be the future of pulmonary hypertension therapy?

This editorial refers to ‘Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension’ by R. Adãoet al., pp.1165 –1177.
Source: Cardiovascular Research - Category: Cardiology Source Type: research